A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) before it starts. Plus, it could reduce harsh treatments, empower high-risk ...
Sacituzumab govitecan targets Trop-2 and delivers potent chemo directly to TNBC cells. PARP inhibitors are effective in TNBC patients with BRCA mutations. Immune checkpoint inhibitors benefit patients ...
Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback